A Biochemical Society Event
Organ-on-a-Chip is a hot topic and one of keen interest to many scientists working in translational sciences. Whilst the technology is still in its infancy, Organ-on-a-Chip is expected to deliver game changing solutions and progressively increase our capacity to gain greater insight into mechanisms of human disease, toxicity and early efficacy assessment of new therapies. There are many Organ-on-a-Chip start-ups that have developed within academic institutions and are now attracting interest and financial investment. This conference will review where the current state of the art is, and where the bottle necks and future directions lay.
Our objective will be to encourage our speakers to adopt an honest stance in their account with a view to addressing some of the critical questions that will help frame the presentations and discussions. Questions such as ‘how was the relevance to human biology assessed' or ‘how well does it replicate human physiology or disease processes' will be at the forefront of presentations and discussions. The two speakers chosen amongst commercial model developing companies are well respected scientists with a strong expertise in human patho-physiology; they will be asked to illustrate how challenges in human patho-physiology modelling are being dealt with and which solutions can be realistically envisaged.
For further details and to book please visit the Biochemical Society website
Continuing Professional Development (CPD)
This event is approved by the Royal Society of Biology for purposes of CPD
and may be counted as 18 CPD credits